Header Logo

Connection

Ian Dunn to Gene Dosage

This is a "connection" page, showing publications Ian Dunn has written about Gene Dosage.
Connection Strength

0.278
  1. Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary Tumors. Endocrinology. 2017 07 01; 158(7):2284-2291.
    View in: PubMed
    Score: 0.141
  2. Genomic characterization of recurrent high-grade astroblastoma. Cancer Genet. 2016 Jul-Aug; 209(7-8):321-30.
    View in: PubMed
    Score: 0.033
  3. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol. 2016 05; 18(5):649-55.
    View in: PubMed
    Score: 0.032
  4. Integrative genomic approaches to understanding cancer. Biochim Biophys Acta. 2009 Jun; 1790(6):478-84.
    View in: PubMed
    Score: 0.020
  5. Genomics of human glioblastoma multiforme: a glimpse of the future. Neurosurgery. 2008 Dec; 63(6):15.
    View in: PubMed
    Score: 0.019
  6. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature. 2008 Sep 25; 455(7212):547-51.
    View in: PubMed
    Score: 0.019
  7. HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder. Br J Cancer. 2003 Oct 06; 89(7):1305-9.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.